Offer - Urjas Oil for just ₹ 1
Rosugraf F is a commercial drug that is prescribed in the form of Tablet. Rosugraf F also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Rosugraf F. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Rosugraf F also has some side effects, the most common being Nausea or vomiting, Headache, Constipation. Apart from the aforementioned side effects, Rosugraf F can also lead to other problems, which have been listed below. Usually, these side effects of Rosugraf F go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Rosugraf F's effect is Moderate during pregnancy and Moderate for lactating mothers. Warnings related to Rosugraf F's effects on the liver, heart and kidney, if any, have been listed below.
Rosugraf F is not recommended if you suffer from certain medical conditions as it can have adverse effects. Diabetes are examples of such conditions.
Drug interactions for Rosugraf F have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Rosugraf F is considered not safe while driving, and is not addictive.
Rosugraf F is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Adult |
|
| Geriatric |
|
Is the use of Rosugraf F safe for pregnant women?
Rosugraf F may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Rosugraf F again without your doctor's advice.
Is the use of Rosugraf F safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Rosugraf F. Immediately discontinue Rosugraf F if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Rosugraf F on the Kidneys?
Rosugraf F rarely affects the kidneys.
What is the effect of Rosugraf F on the Liver?
Side effects of Rosugraf F rarely affect the liver.
What is the effect of Rosugraf F on the Heart?
Rosugraf F may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
Rosugraf F should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Rosugraf F unless your doctor advises you to do so -
Is this Rosugraf F habit forming or addictive?
Forming a habit of Rosugraf F has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Rosugraf F. So it is best to avoid driving.
Is it safe?
Rosugraf F should be used only after doctor's advice.
Is it able to treat mental disorders?
Rosugraf F is unable to treat or cure mental disorders.
Interaction between Food and Rosugraf F
There isn't any research available on the side effects of taking Rosugraf F with food.
Interaction between Alcohol and Rosugraf F
Information about the interaction of Rosugraf F and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
